Skip to content

The Effect of Alginate Encapsulated Supplements on Athletic Performance and Recovery

The Effect of Alginate Encapsulated Supplements on Athletic Performance and Recovery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06165393
Acronym
SWAP
Enrollment
20
Registered
2023-12-11
Start date
2022-05-11
Completion date
2023-12-31
Last updated
2023-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletic Performance

Brief summary

Endurance sport is often characterized by high training loads and significant metabolic demands, including depletion of endogenous fuel stores (e.g. liver and muscle glycogen) and damage to the skeletal muscle proteins. Nutritional interventions that enhance the restoration of endogenous fuel stores and improve muscle damage repair have received a lot of attention. The primary aim of this project is to clinically test the effect of alginate encapsulation technology on performance. Furthermore, we will investigate the substrate utilization profile during exercise and subsequent recovery. The encapsulation technology presents a nutrient delivery solution, which results in a sustained or slow-release of the nutrients encapsulated. Thus, potentially optimizing the digestion and absorption by promoting an easy ingestion of high concentrations of fx carbohydrates without negatively affecting the gastrointestinal comfort.

Interventions

DIETARY_SUPPLEMENTSlow-release CHO-AA

Slow-release CHO-AA, alginate encapsulated

DIETARY_SUPPLEMENTSlow-release CHO

Slow-release CHO, alginate encapsulated

DIETARY_SUPPLEMENTCHO

Carbohydrate-only, control

Sponsors

Innovation Fund Denmark
CollaboratorINDIV
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* males between 18-50 years of age * moderate to trained individuals with a VO2max \> 50 ml/min/kg * accustumed to exercising on a bike * healthy volunteers

Exclusion criteria

* persons diagnosed with metabolic diseases (i.e. Type 2 Diabetes) which relates to the carbohydrate metabolism. * persons ingesting prescribed drugs/medicin, supplements or a special diet (i.e. low carbohydrate), which might affect the glycogen synthesis and/or performance.

Design outcomes

Primary

MeasureTime frameDescription
Performanceapprox. 90 min-120 minTime-To-Exhaustion performance test

Countries

Denmark

Contacts

Primary ContactPer B Jeppesen, PhD
per.bendix.jeppesen@clin.au.dk+4528151877
Backup ContactLotte L Nielsen, M.Sc.
lln@clin.au.dk+4522995827

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026